Brain stimulation trial reports delayed cognitive changes, with the mechanism still uncertain
In people with memory-related mild cognitive impairment or very mild Alzheimer's disease, the trial reported later cognitive improvement but no immediate change in a glymphatic imaging measure.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The trial reported cognitive improvement at week 6 after active stimulation, but no immediate change in cognition or the imaging measure of glymphatic activity. The sham group began active treatment after week 2, and the abstract does not specify the comparison behind the later improvement. This leaves the size and interpretation of that finding uncertain.
The abstract omits cognitive test names, effect sizes and the reference comparison for the delayed finding. It also does not establish a glymphatic mechanism or durable clinical benefit.
Separate cognitive and imaging outcomes
Researchers used intermittent theta-burst stimulation directed at the left prefrontal cortex. They assessed cognition alongside the ALPS imaging index, a measure used here to investigate glymphatic activity; these were separate outcomes.
Safety observations have limits
No adverse events were reported. That observation is limited to this trial's participants and follow-up; it cannot establish broad safety or show that cognitive changes persist beyond the reported assessments.
The original publication
Effects of intermittent theta-burst stimulation on cognition and glymphatic system activity in mild cognitive impairment and very mild Alzheimer's disease: a randomized controlled trial.
Yang CC, Huang KY, Hsu JL et al.
J Neuroeng Rehabil · 2025
- PubMed ID
- 41013466
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.